Outsourced Pharma Capacity Update

Published on January 26, 2024

Abzena’s CTO, Dr Louise Duffy, will be presenting at the virtual Outsourced Pharma Capacity Update for Large Molecules on Feb. 13.

Louise’s talk will touch on cell line development, bioassays, bioconjugations and process development & manufacturing strategies for streamlining the development of biologics and bioconjugates.

To register for this event, click here.

The post Outsourced Pharma Capacity Update appeared first on abzena.

Continue reading on website
Other news

Contract Pharma: Trends in the Development of ADCs

January 25, 2024
Targeting tumor heterogeneity with antibody-drug conjugates (ADCs) and novel payloads.In Contract Pharma’s latest issue, Abzena’s CTO, Dr Louise Duffy discusses the evolution of antibody-drug conjugates (ADCs) and how they represent a promising approach to tackling tumor heterogeneity. She shares insights into recent advancements in payloads that modulate the immune system and provides insights in

Next Generation Conjugates Summit

January 26, 2024
Planning to attend the Next Generation Conjugates Summit in Boston, MA on Feb. 26-28?  Make sure to connect with Abzena!Our SVP & Scientific Leader, Dr. Petra Dieterich and Sr. Director of Chemistry, Dr Nicolas Camper will be giving a workshop on Day 1 of the event entitled:“The Nuts & Bolts of Progressing Next Generation Bioconjugates from Lead Selection through Process Development & Manufacturin